Ovarian cancer

• Health & Medicine

Ovarian cancer survival doubles in 30 years

Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today. Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today.

9 March 2011

• Health & Medicine

AstraZeneca and Pfizer join Cancer Research UK's Stratified Medicine Programme

Cancer Research UK will be supported by AstraZeneca and Pfizer in a multimillion pound initiative to examine how genetic tests to improve cancer diagnosis can be best rolled out across the NHS. Cancer Research UK will be supported by AstraZeneca and Pfizer in a multimillion pound initiative to examine how genetic tests to improve cancer diagnosis can be best rolled out across the NHS.

1 February 2011

• Health & Medicine

New study shows that cancer survival is improving, but there's more work to be done

22 December 2010

Deprived cancer patients face fatal health problems

Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows. Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows.

24 November 2010

• Health & Medicine
• Science & Technology

NCRI conference: An interview with Professor Stan Kaye

8 November 2010

• Health & Medicine
• Science & Technology

NCRI conference: making progress in treating ovarian cancer

8 November 2010

• Health & Medicine

Test selects the 60 per cent of women with inherited ovarian cancer who could benefit from 'smart' drug

Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool. Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool.

8 November 2010

• Science & Technology

Researchers discover genetic ‘volume control’ for inherited breast cancers

28 September 2010

Scientists discover first DNA region to alter breast cancer risk in women with BRCA1 faults

Cancer Research UK scientists have identified a DNA region which can increase or decrease the high breast cancer risk associated with the BRCA1 gene. Cancer Research UK scientists have identified a DNA region which can increase or decrease the high breast cancer risk associated with the BRCA1 gene.

19 September 2010

• Science & Technology

A step forward in understanding the BRCA2 ‘cancer gene’

Scientists have finally managed to purify the entire BRCA2 protein. Scientists have finally managed to purify the entire BRCA2 protein.

27 August 2010

• Science & Technology
• Health & Medicine

International drug trials underline the future of cancer treatment

18 August 2010

• Science & Technology

‘Starvation gene’ could make resistance futile for ovarian cancer cells

17 August 2010